OBALON THERAPEUTICS INC·4

Oct 28, 4:31 PM ET

Hussainy Nooshin 4

4 · OBALON THERAPEUTICS INC · Filed Oct 28, 2019

Insider Transaction Report

Form 4
Period: 2019-10-25
Hussainy Nooshin
VP of Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-10-25+11,68211,682 total
    Exercise: $1.75Exp: 2029-10-25Common Stock (11,682 underlying)
  • Award

    Stock Options (Right to Buy)

    2019-10-25+9,0009,000 total
    Exercise: $1.75Exp: 2029-10-25Common Stock (9,000 underlying)
Footnotes (2)
  • [F1]The Option shall vest as to (i) 25% of the shares of Common Stock underlying the Stock Option on October 19, 2020 and (ii) 1/48th of the shares of Common Stock underlying the Stock Option on each monthly anniversary of October 19, 2020 thereafter, subject to the grantee's continued service with the Company through the applicable vesting date.
  • [F2]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.

Documents

1 file
  • 4
    marketforms-45993.xmlPrimary

    PRIMARY DOCUMENT